Tert-butyl N-[(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethyl]carbamate;(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethanamine;2,2,2-trifluoroacetic acid
C47H43Cl2F3N12O6 — CID 159722891
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethyl]carbamate;(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethanamine;2,2,2-trifluoroacetic acid
Tert-butyl N-[(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethyl]carbamate;(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethanamine;2,2,2-trifluoroacetic acid (PubChem CID 159722891) has the molecular formula C47H43Cl2F3N12O6 and a molecular weight of 999.84 g/mol. Its IUPAC name is tert-butyl N-[(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethyl]carbamate;(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethanamine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | Tert-butyl N-[(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethyl]carbamate;(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethanamine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 159722891 |
| Molecular Formula | C47H43Cl2F3N12O6 |
| Molecular Weight | 999.84 g/mol |
| Exact Mass | 998.28 |
| IUPAC Name | tert-butyl N-[(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethyl]carbamate;(1S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-oxidopyridin-1-ium-2-yl]-2-phenylethanamine;2,2,2-trifluoroacetic acid |
| SMILES | CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)c1ccc(-c2cc(Cl)ccc2-n2cnnn2)c[n+]1[O-].N[C@@H](Cc1ccccc1)c1ccc(-c2cc(Cl)ccc2-n2cnnn2)c[n+]1[O-].O=C(O)C(F)(F)F |
| InChI | InChI=1S/C25H25ClN6O3.C20H17ClN6O.C2HF3O2/c1-25(2,3)35-24(33)28-21(13-17-7-5-4-6-8-17)23-11-9-18(15-32(23)34)20-14-19(26)10-12-22(20)31-16-27-29-30-31;21-16-7-9-19(26-13-23-24-25-26)17(11-16)15-6-8-20(27(28)12-15)18(22)10-14-4-2-1-3-5-14;3-2(4,5)1(6)7/h4-12,14-16,21H,13H2,1-3H3,(H,28,33);1-9,11-13,18H,10,22H2;(H,6,7)/t21-;18-;/m00./s1 |
| InChIKey | OXEMANSKQQMOHU-SVMNOAKXSA-N |
| XLogP | 7.92 |
| TPSA | 242.73 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 70 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 999.84 |
| LogP ≤ 5 | 7.92 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159722891 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.